A histopathologic analysis of eyes primarily enucleated for advanced intraocular retinoblastoma from a developing country

Archives of Pathology and Laboratory Medicine

Volumn 136, Issue 2, 2012, Pages 190-193

  Kashyap, Seema ^a   Sethi, Sumita ^a   Meel, Rachna ^a   Pushker, Neelam ^a   Sen, Seema ^a   Bajaj, Mandeep Singh ^a   Chandra, Mahesh ^a   Ghose, Supriyo ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CHOROID; DEVELOPING COUNTRY; ENUCLEATION; EYE; FEMALE; HUMAN; INFANT; MALE; OPTIC NERVE; PATHOLOGY; PRESCHOOL CHILD; RETINA TUMOR; RETINOBLASTOMA; RETROSPECTIVE STUDY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHOROID; DEVELOPING COUNTRIES; EYE; EYE ENUCLEATION; FEMALE; HUMANS; INFANT; MALE; OPTIC NERVE; RETINAL NEOPLASMS; RETINOBLASTOMA; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84856624539     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2010-0759-OA     Document Type: Article

References (34)

1. Kivelä T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 2009;93(9):1129-1131.
2. Biswas J, Das D, Krishnakumar S, Shanmugam MP. Histopathologic analysis of 232 eyes with retinoblastoma conducted in an Indian tertiary-care ophthalmic center. J Pediatr Ophthalmol Strabismus. 2003;40(5):265-267.
3. Vemuganti G, Honavar S, John R. Clinicopathological profile of retinoblastoma patients in Asian Indians. Invest Ophthalmol Vis Sci. 2000;41(S):790.
4. Orellana ME, Fernandes BF, Arean C, Pifano I, Al-Kandari A, Burnier MN Jr. Clinical pathologic study of a cohort of patients with retinoblastoma from a developing country. J Pediatr Ophthalmol Strabismus. 2009;46:294-299.
5. Gupta R, Vemuganti GK, Reddy VA, Honavar SG. Histopathologic risk factors in retinoblastoma in India. Arch Pathol Lab Med. 2009;133(8):1210-1214.
6. Dimaras H, Dimba EA, Gallie BL. Challenging the global retinoblastoma survival disparity through a collaborative research effort. Br J Ophthalmol. 2010; 94(11):1415-1416.
7. Chantada G, Fandiño A, Manzitti J, Urrutia L, Schvartzman E. Late diagnosis of retinoblastoma in a developing country. Arch Dis Child. 1999;80(2):171-174.
8. Canturk S, Qaddoumi I, Khetan V, et al. Survival of retinoblastoma in lessdeveloped countries impact of socioeconomic and health-related indicators. Br J Ophthalmol. 2010;94(11):1415-1416.
9. Sastre X, Chantada GL, Doz F, et al. Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma. Arch Pathol Lab Med. 2009;133(8):1199-1202.
10. Children's Oncology Group. Phase III study of adjuvant vincristine, carboplatin, and etoposide or observation only in patients with newly diagnosed unilateral retinoblastoma with or without histopathologic high-risk features after enucleation. National Cancer Institute. Protocol IDs COG-ARET0332, NCT00335738. http//www.cancer.gov/search/clinicaltrials. Published June 2, 2006. Updated May 18, 2010. Accessed September 28, 2010.
11. Mehta M, Sethi S, Pushker N, Chawla B, Ghose S. Retinoblastoma: still a challenge in developing countries [published online ahead of print May 28, 2010]. Acta Ophthalmol. 2011;89(4):e371. doi: 10.1111/j.1755-3768.2010.01937.x.
12. MacCarthy A, Birch JM, Draper GJ, et al. Retinoblastoma in Great Britain 1963-2002. Br J Ophthalmol. 2009;93(1):33-37.
13. Ghose S, Kashyap S, Sen S, Sethi A, Pushker N, Balasurbramanya R. Histopathology of unilateral and bilateral retinoblastomas. Indian J Pathol Microbiol. 2004;47(1):131.
14. Madhavan J, Ganesh A, Roy J, Biswas J, Kumaramanickavel G. The relationship between tumor cell differentiation and age at diagnosis in retinoblastoma. J Pediatr Ophthalmol Strabismus. 2008;45(1):22-25.
15. Eagle RC Jr. High-risk features and tumor differentiation in retinoblastoma: a retrospective histopathologic study. Arch Pathol Lab Med. 2009;133(8):1203-1209.
16. Filho JP, Correa ZM, Odashiro AN, et al. Histopathological features and Pglycoprotein expression in retinoblastoma. Invest Ophthalmol Vis Sci. 2005; 46(10):3478-3483.
17. Helm J, Enkemann SA, Coppola D, Barthel JS, Kelley ST, Yeatman TJ. Dedifferentiation precedes invasion in the progression from Barrett's metaplasia to esophageal adenocarcinoma. Clin Cancer Res. 2005;11(7):2478-2485.
18. Santos L, Loo C, Chandraratnam E, Gune S. Anaplastic carcinoma dedifferentiation of solid variant of papillary thyroid carcinoma. Pathology. 2004;36(2):196-211.
19. Chong EM, Coffee RE, Chintagumpala M, Hurwitz RL, Hurwitz MY, Chévez-Barrios P. Extensively necrotic retinoblastoma is associated with high-risk prognostic factors. Arch Pathol Lab Med. 2006;130(11):1669-1672.
20. Shields CL, Shields JA, Baez KA, Cater J, De Potter PV. Choroidal invasion of retinoblastoma: metastatic potential and clinical risk factors. Br J Ophthalmol. 1993;77(9):544-548.
21. Shields CL, Shields JA, Baez K, Cater JR, De Potter P. Optic nerve invasion of retinoblastoma. Metastatic potential and clinical risk factors. Cancer 1994; 73(3):692-698.
22. Magramm I, Abramson DH, Ellsworth RM. Optic nerve involvement in retinoblastoma. Ophthalmology. 1989;96(2):217-222.
23. Kopelman JE, McLean IW, Rosenberg SH. Multivariate analysis of risk factors for metastasis in retinoblastoma treated by enucleation. Ophthalmology. 1987;94(4):371-377.
24. Messmer EP, Heinrich T, Hopping W. Risk factors for metastasis in patients with retinoblastoma. Ophthalmology. 1991;98(2):136-141.
25. Khelfaoui F, Validire P, Auperin A, et al. Histopathologic risk factors in retinoblastoma: a retrospective study of 172 patients treated in a single institution. Cancer. 1996;77(6):1206-1213.
26. Redler LD, Ellsworth RM. Prognostic importance of choroidal invasion in retinoblastoma. Arch Ophthalmol. 1973;90(4):294-296.
27. Chantada GL, Dunkel IJ, de Dávila MT, Abramson DH. Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy? Br J Ophthalmol. 2004;88(8):1069-1073.
28. Wilson MW, Qaddoumi I, Billups C, Haik BG, Rodriguez-Galindo C. A clinicopathological correlation of 67 eyes primarily enucleated for advanced intraocular retinoblastoma [published online ahead of print August 7, 2010]. Br J Ophthalmol. 2011;95(4):553-558. doi:10.1136/bjo.2009.177444.
29. Cuenca A, Giron F, Castro D, et al. Microscopic scleral invasion in retinoblastoma: clinicopathological features and outcome. Arch Ophthalmol. 2009;127(8):1006-1010.
30. Shields CL, Shields JA. Basic understanding of current classification and management of retinoblastoma. Curr Opin Ophthalmol. 2006;17(3):228-234.
31. Azar D, Donaldson C, Kalapesi F, Cumming R. Retinoblastoma in New South Wales 1975 to 2001. J Pediatr Hematol Oncol. 2006;28(10):642-646.
32. Bai S, Ren R, Shi J, et al. Retinoblastoma in the Beijing Tongren Hospital from 1957 to 2006: clinicopathological findings [published online ahead of print July 19, 2010]. Br J Ophthalmol. doi:10.1136/bjo.2010.181396.
33. Ozdemir H, Tacyildiz N, Unal E, Yavuz G, Ugur H, Gunduz K. Clinical and epidemiological characteristics of retinoblastoma: correlation with prognosis in a Turkish pediatric oncology center. Pediatr Hematol Oncol. 2007;24(3):221-231.
34. Menon BS, Alagaratnam J, Juraida E, Mohamed M, Ibrahim H, Naing NN. Late presentation of retinoblastoma in Malaysia. Pediatr Blood Cancer. 2009; 52(2):215-217.